Eravac

RSS

Rabbit haemorrhagic disease vaccine (inactivated)

Authorised
This medicine is authorised for use in the European Union.

Overview

Eravac is a veterinary vaccine used in rabbits to reduce death due to the rabbit haemorrhagic disease (RHD), caused by the variant of RHD virus called RHD type 2 (RHDV2). It is usually a fatal disease resulting in the formation of blood clots.

RHD type 2 virus differs from the classic form of RHD virus since the course of disease is more prolonged, death occurs later and over a longer period and is more severe in young rabbits.

Eravac contains inactivated rabbit haemorrhagic disease type 2 virus, strain V-1037, as the active substance.

This EPAR was last updated on 05/02/2020

Authorisation details

Product details
Name
Eravac
Agency product number
EMEA/V/C/004239
Active substance
For active immunisation of rabbits against Rabbit haemorrhagic disease type 2 virus (RHDV2)For active immunisation of rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (RHDV2)
International non-proprietary name (INN) or common name
Rabbit haemorrhagic disease vaccine (inactivated)
Species
Rabbits
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI08AA
Publication details
Marketing-authorisation holder
Laboratorios Hipra, S.A.
Revision
4
Date of issue of marketing authorisation valid throughout the European Union
22/09/2016
Contact address

Avda. La Selva, 135
17170 Amer (Girona)
Spain

Product information

27/01/2020 Eravac - EMEA/V/C/004239 - II/0005/G

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Inactivated viral vaccines

Therapeutic indication

For active immunisation of rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (RHDV2)

Assessment history

How useful was this page?

Add your rating
Average
1 rating